IN8bio, Inc. (INAB) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by IN8bio, Inc. on February 5, 2025. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "INAB". The filing addresses a listing status change and the scheduling of the 2025 Annual Meeting of Stockholders.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and listing compliance rather than financial performance.
Material Changes
- Nasdaq Listing Transfer: Effective February 7, 2025, the company's common stock was transferred from the Nasdaq Global Market to the Nasdaq Capital Market.
- Compliance Extension: Nasdaq granted an extension until August 4, 2025, to regain compliance with the minimum closing bid price requirement of $1.00 per share (Nasdaq Listing Rule 5550(a)(2)).
- Annual Meeting Date: The 2025 Annual Meeting of Stockholders is scheduled for May 8, 2025, which is more than 30 days earlier than the anniversary of the 2024 meeting.
Outlook, Risks, and Management Commentary
Delisting Risk: If the company fails to demonstrate compliance with the $1.00 minimum bid price requirement by August 4, 2025, Nasdaq will notify the company of delisting. The company may appeal this determination to a Nasdaq Hearings Panel.
Remediation Strategy: Management intends to actively monitor the bid price and considers available options to resolve the deficiency, including effecting a reverse stock split if necessary.
Shareholder Actions: Stockholders must submit proposals or director nominations by February 17, 2025, to be considered for the May 8, 2025, Annual Meeting. Notices for universal proxy solicitations are due by March 9, 2025.
Key Facts for Investor Verification
- Verify the current closing bid price of INAB stock relative to the $1.00 threshold.
- Monitor the company's announcement regarding a potential reverse stock split before the August 4, 2025, deadline.
- Confirm the record date for the 2025 Annual Meeting is March 12, 2025.
- Check for any subsequent filings regarding the outcome of the compliance period or the definitive proxy statement for the Annual Meeting.